2008
DOI: 10.1007/s00115-008-2437-y
|View full text |Cite
|
Sign up to set email alerts
|

Eosinophile Pneumonie als unerwünschte Arzneimittelwirkung

Abstract: Eosinophilic pneumonia is a lung disorder characterized by eosinophilic pulmonary infiltration and blood eosinophilia. It can be caused by a variety of drugs. Especially in mild forms and in chronically neurologically ill patients, it can be difficult to spot. We report the case of a 46-year-old woman suffering from multiple sclerosis who developed nitrofurantoin-induced eosinophilic pneumonia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…CXRs in drug-associated PIE demonstrate nonspecific findings including pleural effusion, reticulonodular densities, consolidation and hilar adenopathy (10). In a study of 22 patients with drugassociated PIE syndrome, thin-section computed tomography also showed nonspecific findings including airspace consolidation and peripheral predominance (30%), and bronchial wall thickening and bronchiectasis (5%) (11). The gold standard method to diagnose drug-associated PIE is with a drug provocation/challenge test.…”
Section: Discussionmentioning
confidence: 99%
“…CXRs in drug-associated PIE demonstrate nonspecific findings including pleural effusion, reticulonodular densities, consolidation and hilar adenopathy (10). In a study of 22 patients with drugassociated PIE syndrome, thin-section computed tomography also showed nonspecific findings including airspace consolidation and peripheral predominance (30%), and bronchial wall thickening and bronchiectasis (5%) (11). The gold standard method to diagnose drug-associated PIE is with a drug provocation/challenge test.…”
Section: Discussionmentioning
confidence: 99%
“…Nitrofurantoin is associated with acute or subacute pneumonitis (ILD) characterized generally with bilateral and symmetric pulmonary opacities. Pulmonary fibrosis, eosinophilic pneumonia, or pleuropathy (discussed later) may be present with restrictive lung dysfunction and hypoxemia, which usually resolve after the drug is discontinued [172][173][174].…”
Section: Drug-induced Parenchymal and Interstitial Lung Disease (Ild)mentioning
confidence: 99%